OXB is a quality and innovation-led CDMO with over 25 years of experience, committed to helping clients deliver cell and gene therapies that transform patients’ lives. OXB provides viral vector development and manufacturing expertise in lentivirus, AAV, adenovirus and other viral vector types. OXB’s end-to-end capabilities span from plasmid design and optimisation to clinical and commercial GMP manufacturing. These capabilities are supported by robust quality systems, analytical methods, and deep regulatory knowledge.
We know the challenges and we’re ready.